Displaying 11 (all) recruiting clinical trials.
-
A Phase 1 Trial of JNJ-98768111 an Antibody Drug Conjugate (ADC) Targeting Human Kallikrein-2 (KLK2) for Advanced Prostate Cancer
This Phase 1 study is testing a new drug called JNJ-98768111 in people with metastatic prostate cancer, meaning prostate cancer that has spread to other ...
Phase
Interventional
